Nucleic acid tests are performed in order to detect the presence of viral DNAs or RNAs in blood samples of patients. Three major processes involved in NAT are sample pooling and nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection.Major NAT technologies include polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and nucleic acid sequence based amplification (NASBA). Based on its major applications, NAT market can be classified into five major segments namely infectious diseases, genetic diseases, cancer, forensic testing and paternity testing.
Obtain the Insights for the Forthcoming Market Analysis of Nucleic Acid at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1834
The primary growth drivers for the global nucleic acid testing market are the high incidence of infectious diseases and other chronic diseases such as cancer and genetic diseases. Furthermore, the increasing demand for technological advancements in ways of testing, rising acceptance from end users, and supportive regulatory framework are also expected to drive the global nucleic acid testing market. Research indicates that about one billion people fell prey to infectious diseases in 2012, which has lent a huge impetus to this market and will become the deciding factor in its growth trajectory in the coming years.
The global nucleic acid testing market is segmented on the basis of application into infectious diseases, cancer, genetic diseases, paternity testing, and forensic testing. On the basis of process, this market is segmented into sample pooling and nucleic acid (NA) extraction, target amplicon NA detection, and target NA amplification. Depending on the technology, this market is segmented into transcription-mediated amplification (TMA), polymerase chain reaction (PCR), ligase chain reaction (LCR), strand displacement amplification (SDA), and nucleic acid sequence based amplification (NASBA). Geographically, this market is segmented into North America, Asia Pacific, Europe, and Rest of the World.
Some of the important players in the global nucleic acid testing market are Gen-Probe, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Siemens Healthcare, Bio-Rad Laboratories, Inc., Illumina, Inc., bioMérieux SA, Novartis AG, F. Hoffmann-La Roche Ltd., Sequenom, Inc. Tecan Group Ltd., and Beckman Coulter, Inc. The research report profiles these players and offers a detailed explanation of how the market’s competitive landscape is going to pan out in the coming few years. Additionally, the report also provides an analysis of the financial overview, research and development strategies, investment outlook, business and marketing strategies, and strategic mergers and acquisitions of these top players for the near future.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453